efficacy 1
safety 1
dupilumab 1
adults 1
moderatetosevere 1
atopic 1
dermatitis 1
inadequately 1
controlled 1
topical 1
treatments 1
randomised 1
placebocontrolled 1
doseranging 1
phase 1
b 1
trial 1
